Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,583.38
(
0.26%
)
US TECH 100
29,504.60
(
0.27%
)
Dow Jones
51,003.30
(
0.66%
)
Brent Oil
91.31
(
-0.95%
)
Bitcoin
73,590.45
(
0.07%
)
News Focus
News Focus
Post# of 616
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123037
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 3

Thursday, 01/21/2016 9:59:51 AM

Thursday, January 21, 2016 9:59:51 AM

Post# of 616
VTVT starts phase-2 trial of TTP273 in T2D:

http://finance.yahoo.com/news/vtv-therapeutics-initiates-phase-2-120000796.html

VTVT has two distinct programs in type2 diabetes; both are expected to report phase-2 data during 2016.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent VTVT News
More VTVT News